LINDZEE BAKER: Open Payments
NPI 1932827318 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 72 payments from 27 companies in 2025. Trend: 2023 $1,926 · 2024 $1,981 · 2025 $1,993
Food & beverage: $1,993
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $359 |
| Lilly USA, LLC | 7 | $205 |
| Amgen Inc. | 4 | $196 |
| ViiV Healthcare Company | 2 | $148 |
| Novo Nordisk Inc | 7 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| GlaxoSmithKline, LLC. | 3 | $86 |
| Gilead Sciences, Inc. | 3 | $79 |
| Hologic Sales and Service, LLC | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
Products named: AIRSUPRA, APRETUDE, MOUNJARO, APTIMA, BREZTRI, XIFAXAN, FARXIGA, EVENITY.
Industry payments across CA — which companies pay providers there.
